23. Symposium of the AGNP

Abstracts (HTML) List of Authors

Bachus, R.

Saccadic eye movements and cognitive performance in schizophrenic patients treated with clozapine or flupentixol

Bäcker, A.

Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm

Baethge, C.

Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects

Baghai, T. C.

Influence of mirtazapine on salivary cortisol in depressed patients
Different protein expression levels after antidepressant treatment on EBV cells of depressed patients
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Gender influence on pharmacogenetic prediction of antidepressive efficacy
α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization

Bahra, R.

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Baier, C.

Restaurative therapy for Parkinson’s disease

Bajbouj, M.

EEG source localization during postictal delirium following electroconvulsive therapy
Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability
Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing
Altered cortical inhibition after electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS)
Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis

Banac, S.

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Bandelow, B.

Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration

Barbosa, E.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia

Barbosa, N. R.

Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment

Barnas, C.

The influence of somatic conditions on benzodiazepine long-term use

Bartels, M.

Treatment of tics in Tourette’s syndrome with aripiprazole

Bartenstein, P.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Barth, U.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Bartl, C.

Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants

Bauer, A.

Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study

Bauer, M.

Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study
Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression
Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients
Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects

Baumann, B.

Effects of antidepressants in postmortem and neuroimaging studies

Baumann, P.

Influence of metabolic processes on course and treatment of opioid-dependence
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Interactions between somatic and psychotropic drugs: pharmacokinetic and pharmacodynamic consequences.

Baumgart, U.

Rhabdomyolysis associated with olanzapine monotherapy – A case report

Baumgartner, S.

Alterations of glucose metabolism under treatment with atypical antipsychotics

Bayerlein, K.

Leptin plasma levels and craving data during alcohol withdrawal
Craving differs with alcoholic beverages

Bechtel, G.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Leptin levels of alcohol abstainers and detoxification patients are not different

Becker, A.

Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results
Kindling alters rewarding effects of ethanol, morphine and cocaine

Behl, C.

Antioxidants and hormones: Implications for neurodgenerative disorders and aging

Beissbarth, T.

cDNA arrays analyses in an animal model for psychosis-related traits

Bender, S.

Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP
The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram
Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program

Benninghoff, J.

The serotonergic receptor 2C subtype (5-HT2C) regulates survival and proliferation of adult neural stem cells (ANSC) derived from mouse hippocampus

Berendt, F.

Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease

Berg, T.

Interferon-alpha treatment and serotonergic dysfunction

Bergemann, N.

Therapeutic drug monitoring data: No influence of amisulpride on clozapine plasma concentration

Berger, C.

Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy

Berger, M.

Transient narcolepsy-cataplexy-syndrome after discontinuation of the antidepressant venlafaxine
Modulation of neuropeptidergic circuits
Substance P and substance P antagonists in the pathology and treatment of affective disorders
Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells
Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P

Bergmann, A.

Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Berman, S. M.

Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study

Bernhardt, K.

A new concept for crisis management in borderline patients

Bernstein, H. G.

Effects of antidepressants in postmortem and neuroimaging studies
The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study

Bertling, R.

Effectiveness of music therapy on pain reduction and psychopharmacotherapy

Bielau, H.

Effects of antidepressants in postmortem and neuroimaging studies

Bilkei-Gorzo, A.

New insights into the role of the opioid system as mediator of drug addiction by studies in transgenic mice

Binder, E.

Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders

Binder, E. B.

ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders
Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes
Prediction of response to antidepressant monotherapy
Is there a genetic continuum between anxiety and depression?

Birg, I. N.

Validation of a genetic mouse model for anxiety and comorbid depression
Analysis of cerebrospinal fluid of depressed patients

Birkenbach-Holdschuh, T.

A new measure of the dopamine challenge by bromocriptine for testing personality

Birkmann, S.

Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders

Blaha, L.

Predicting successful job performance of schizophrenics after discharge from hospital

Bleich, S.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Leptin plasma levels and craving data during alcohol withdrawal
Craving differs with alcoholic beverages
Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration
Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy

Blennow, K.

A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia

Block, W.

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Bodner, T.

Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?

Boerner, R. J.

Naturalistic follow-up study of pharmacologic treated patients with anxiety disorders
New scales for measuremant of anxiety in a study with hydroxyzine for patients with generalized anxiety disorder (GAS)

Bogerts, B.

Different inhibitory mechanism in BALB-c and CPB/K mice using the prepulse inhibition paradigm – An animal model for schizophrenia?
Effects of antidepressants in postmortem and neuroimaging studies
The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study

Boigs, M.

Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity
Modulation of sleep: A new approach of treating memory impairment in schizophrenia?

Bokde, A. L. W.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Neural representation of cognitive changes within the visual system in the AD brain

Bölte, S.

The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects

Bondy, B.

Different protein expression levels after antidepressant treatment on EBV cells of depressed patients
Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Gender influence on pharmacogenetic prediction of antidepressive efficacy
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene
Is there a common basis between psychiatric and somatic diseases

Bonert, A.

Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway

Bopp, G.

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Borgwardt, S.

Cognitive function and psychomotor performance in schizophrenic patients

Born, C.

Neural representation of cognitive changes within the visual system in the AD brain

Bottino, C. M. C.

Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex
Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment

Bottlender, R.

Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up

Bozkurt, B.

Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings

Brand, S.

Predictive value of sleep EEG markers in long-term course of depression

Braun, H. A.

Computational biology of sensitization: Pharmacologically- relevant amplification mechanisms

Braun, S.

Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity
Modulation of sleep: A new approach of treating memory impairment in schizophrenia?

Braus, D.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients

Braus, D. F.

Relapse and gender specific activation of the striatum in alcohol dependent patients

Brettschneider, S.

Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Breu, J.

Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides

Brockmöller, J.

Pharmacogenetics based therapeutic recommendations in antidepressant drug therapy
Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients

Bronisch, T.

High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression

Brückmann, H.

Differences in cortical activation by a working memory task after substitution of atypical neuroleptics

Brunner, E.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Brunner, H.

Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression

Brunner, J.

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression
Prediction of response to antidepressant monotherapy

Brunnmeier, M.

Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity

Bschor, T.

Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects

Bublak, P.

A new diagnostic tool for measuring attentional components in patients with depression

Buchholz, H. G.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Bunck, M.

Validation of a genetic mouse model for anxiety and comorbid depression

Bürger, K.

Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Burgmair, W.

50 years of chlorpromazine – Serendipity or necessity

Burtscheidt, W.

Alcohol-craving: Therapeutic effects using fMRI
Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal

Bymaster, F.

Pharmacologic properties of atomoxetine: a novel treatment for attention deficit/hyperactivity disorder